CD34 and acute myeloid leukemia: Finally, AML-derived small EVs carrying miR-7977 have been described to reduce MSCs ability to support CD34+ progenitor cells in the bone marrow, resulting in alterations in proliferation and migration MSCs and hematopoietic progenitor [188].